21 Feb 2017 | 1:07 AM
 

Ind-Swift Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 532305 | NSE Symbol: INDSWFTLAB
36.00
0.15
(0.42 %)
20 Feb 2017 | 04:01 PM
Change company
  • Open (Rs)
    36.10
  • Prev. close (Rs.)
    35.85
  • High (Rs.)
    37.50
  • Low (Rs.)
    35.80
  • 52W H (Rs.)
    53.00
  • 52W L (Rs.)
    33.60
  • Volume (Rs.)
    20250
  • MCap (Rs in Cr.)
    160.98
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-14.33
Operating Margin (%)
16.68
Gross Profit Margin (%)
3.71
Net Profit Margin (%)
-8.98
Total Debt/Equity
5.36
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

05 Sep 2012 - 09:38:00-Shares of drug maker Ind-Swift Laboratories plunged nearly 6 per cent on the Bombay Stock Exchange a...
17 May 2012 - 13:34:00-Ind-swift one of the leading pharmaceutical companies in India known for its drug research and d...
17 May 2012 - 10:41:00-Buoyed by the launching of Atorvastatin Tablets in UK shares of drug making company Ind-Swift Ltd ...
12 Apr 2012 - 11:30:00-Shares of Ind-Swift laboratories soared nearly 6 per cent after the news that company got USFDA appr...

Announcements

14-Feb-2017
Ind-Swift Laboratori - Standalone Financial Results Limited Review Report for December 31 2016
14-Feb-2017
Ind-Swift Laboratories Ltd. - Reply to Clarification Sought
09-Feb-2017
Ind-Swift Laboratori - Intimation about fire In the manufacturing block of the Company
09-Feb-2017
Ind-Swift Laboratories Ltd. - Clarification
27-Jan-2017
Ind-Swift Laboratori - Board Meeting Intimation for Results & Closure of Trading Window

Religare Research

20 Feb 2017 | 02:48 PM
Talwalkars Better Value Fitness Ltd (TBVFL) reported in-line numbers for Q3FY17 with a revenue and P...
20 Feb 2017 | 09:47 AM
The Indian rupee rose against the U.S. currency, as dollar sales by exporters amid gains in local sh...
20 Feb 2017 | 09:46 AM
Agri Fundamental report
20 Feb 2017 | 09:28 AM
• Gold steadied on weaker dollar, registered third weekly gains • Oil eased on concerns over US crud...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors55.49%
Mutual Funds/UTI0.00%
FI/Banks0.17%
Insurance0.17%
FII2.32%
Government0.00%
Others8.41%

Peer Group

Company Intraday Graph
 Kovai Medical Center and Hospital Ltd.
1,100.00(-0.48)
11816
 Merck Ltd.
1,067.20(5.19)
3302
 AstraZeneca Pharma India Ltd.
926.85(0.48)
3274
 Neuland Laboratories Ltd.
900.00(-0.49)
3578

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Ind-Swift Laboratories Ltd.-1.051.650.85
NIFTY(S&P CNX)529.85950.10250.05
BSE SENSEX1,627.082,896.44676.04
BSE 500764.001,461.51518.90

Corporate Details

Key Personal
G Munjal
Non Executive Director
G Munjal
Promoter Non-Exe.Director
Himanshu Jain
Joint Managing Director
Key Address
Registered Office
SCO 850 Shivalik Enclave NAC Manimajra,Chandigarh,Chandigarh

Tel:0172-5061850 2730920, Fax:0172-2730504 2736294

investor@indswiftlabs.com
http://www.indswiftlabs.com
Registrar Office
Alankit Assignment Ltd.
Add. :205-206 Anarkali Complex Jhandewalan Extension

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Ind-Swift Laboratories Ltd. that will help you decide whether to buy, sell or hold Ind-Swift Laboratories Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Ind-Swift Laboratories Ltd.